Q2 2025 Management View Jeffrey Niew, President and CEO, highlighted the company's resilience in the face of evolving tariffs ...

COPENHAGEN, Denmark– May 8, 2025. The global leader in biosolutions, Novonesis, had a strong start to its financial year with organic sales growth of 11% and an adjusted EBITDA margin of 38.3%.

Organic growth for the quarter was 9%, with an adjusted EBITDAC margin of 41.1%, marking a 338 basis point year-over-year increase. The Brokerage segment posted 16% reported revenue growth and 9.5 ...

Givaudan reiterated that its average organic sales growth was set to exceed its target range of 4% to 5% in the years between 2021 and 2025. The average growth stood at 7.2% at the end of 2024.

Publicis Groupe Q1 Organic Revenue Growth At 4.9%; Reaffirms 2025 Guidance April 15, 2025 — 02:01 am EDT Written by RTTNews.com for RTTNews -> ...

Singapore (11.9% growth) and the UAE (11.1%) emerged as standout booking centers, with Switzerland, Hong Kong, and Singapore expected to absorb two-thirds of all new cross-border wealth by 2029.

Standouts include Pamela Anderson's Sonsie to Umberto Giannini's eponymous hair care line, according to data from Spate.

It appeared first on the Bloomberg Terminal. BI-covered insurance brokers may have room for upside to average consensus organic sales growth of 5-6% in 2025 even as price gains slow.

Brink's Q1 2025 call highlights 6% organic growth, 20% AMS/DRS gains, and strong margins. Learn about new partnerships, FX impacts, and growth strategies.

The $450 billion RIA behemoth is elevating a veteran executive at its Focus Partners division shortly after a broader expansion in its leadership.

SS&C's revenue grew 5.1% organically to $1.51 billion, and adjusted EPS expanded 8.3% to $1.44 in the first quarter of 2025. Management nudged full-year organic revenue guidance to 4.4% from 5.0% ...